AATCC Test Method 100, EN ISO 11737-1, ASTM E2149. We can support with global regulatory submissions such as FDA 510(k)

Microbial infection is the cause of the majority of chronic wounds. As such, wounds that are not clinically infected are almost certainly colonised. These types of chronic wounds can therefore be deemed to be at risk of infection.

We support the research and development projects of companies who create products for chronic wounds. We aim to help decrease patient pain as well as the number of amputations resulting from long term chronic wounds, with the hope to improve patient quality of life. We carry out safety and efficacy testing to ATCC, BS EN and ASTM standards. Examples include AATCC Test Method 100, BS EN ISO 11737-1 and ASTM E2149. 

• Direct contact dressings testing, a method adapted from Gallant-Behn et al (2005)
• Shake-flask method adapted from Parsons et al (2005)
• Bacterial barrier testing
• Viral/phage barrier testing
• ex vivo human skin
• ex vivo porcine skin

• CDC biofilm reactor model adapted for wound care testing of dressings based on ASTM E2871 and ASTM E2562.
• Drip flow reactor model adapted for testing wound dressings based on ASTM E2647.
• Porcine skin explant drip flow model based on ASTM E2647.
• Wicking absorbency.

• AATCC Test Method 100: Antibacterial Finishes on Textile Materials.
• Modified AATCC Test Method 100
• AATCC Test Method 147: Antibacterial Activity Assessment of Textile Materials: Parallel Streak Method.
• BS EN ISO 11737-1: Sterilization of Medical devices. Microbiological Methods. Determination of a population of microorganisms on products (Bioburden).

• BS EN 13726-1: Test methods for primary wound dressings. Aspects of absorbency: Free swell absorption, fluid retention and absorption under a fixed load.
• BS EN 13726-3: Test methods for primary wound dressings. Waterproofness.
• BS EN ISO 20743: Textiles, Determination of antibacterial activity of antibacterial finished products.